Add-on Acquisition • Medical Products

Sharp Fluidics Acquires neoSurgical

On April 7, 2020, Sharp Fluidics acquired medical products company neoSurgical

Acquisition Context

This is Sharp Fluidics’ 1st transaction in the Medical Products sector.
This is Sharp Fluidics’ 1st transaction in the United States.
This is Sharp Fluidics’ 1st transaction in Massachusetts.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	April 7, 2020
Target	neoSurgical
Sector	Medical Products
Buyer(s)	Sharp Fluidics
Deal Type	Add-on Acquisition

Target Company

neoSurgical

Newton, Massachusetts, United States

neoSurgical Ltd. is a commercial-stage company focused on being a global leader in the development of innovative surgical products. The company’s initial product is neoClose, approved for sale in the U.S. and Europe and designed to be the new standard for Lap surgery port site closure, a potential $300 million opportunity. neoSurgical was formed n 2007 anis based in Newton, Massachusetts.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Sharp Fluidics

Hayward, California, United States

Category	Company
Sector	Medical Products

DESCRIPTION

Sharp Fluidics LLC is a surgical device company that develops and markets innovative medical technologies and devices to improve surgical closure efficiency and safety.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Medical Products	1 of 1
Type: Add-on Acquisition	1 of 1
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2020	1 of 1

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2020 M&A